캐나다 - 영어 - Health Canada

searchlight pharma inc - framycetin sulfate - dressing - 1% - framycetin sulfate 1% - antibiotics

캐나다 - 영어 - Health Canada

searchlight pharma inc - framycetin sulfate - dressing - 1% - framycetin sulfate 1% - antibiotics

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

aventis pharma - framycetin sulfate - impregnated dressing - 10mg/1gram

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

roussel laboratories limited - framycetin sulfate - impregnated dressing - 1.0 %w/w

캐나다 - 영어 - Health Canada

roussel canada inc. - framycetin sulfate - dressing - 1% - framycetin sulfate 1% - antibiotics

캐나다 - 영어 - Health Canada

roussel canada inc. - framycetin sulfate - dressing - 1% - framycetin sulfate 1% - antibiotics

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - framycetin sulfate 1% - medicated dressing - 1 % - active: framycetin sulfate 1% excipient: lanolin white soft paraffin

싱가포르 - 영어 - HSA (Health Sciences Authority)

covidien private limited - general & plastic surgery - sofradim symbotex™ composite mesh is intended for the reinforcement of abdominal wall soft tissue where a weakness exists, in procedures involving primary abdominal wall and incisional hernia surgeries. the non-absorbable three-dimensional polyester mesh provides long term reinforcement of soft tissues. on the opposite side, the absorbable hydrophilic film minimizes tissue attachment to the mesh in case of direct contact with the viscera.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - framycetin sulfate, quantity: 5 mg/ml - eye and ear drops - excipient ingredients: sodium citrate dihydrate; sodium chloride; benzalkonium chloride; citric acid monohydrate; water for injections - in the eye: conjunctivitis, blepharitis, styes, corneal abrasions and burns. prophylactically following removal of foreign bodies. also indicated for corneal ulcers.in the ear: otitis externa.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - dexamethasone, quantity: 0.5 mg/ml; framycetin sulfate, quantity: 5 mg/ml; gramicidin, quantity: 0.05 mg/ml - ear drops - excipient ingredients: phenethyl alcohol; polysorbate 80; citric acid monohydrate; sodium citrate dihydrate; lithium chloride; purified water; industrial methylated spirit; hydrochloric acid; sodium hydroxide - indications as at 5 october 2000: inflammatory and allergic conditions of the ear, e.g. otitis externa. eczema of the auditory meatus is often present and causes inflammation, exudation and pruritus, which are all rapidly relieved by dexamethasone. infection,often secondary to scratching, is generally due to staphylococci, e. coli, pseudomonas and proteus spp. which respond rapidly to framycetin.